Garry R Cutting
Overview
Explore the profile of Garry R Cutting including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
152
Citations
4937
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Faino A, Gordon W, Buckingham K, Stilp A, Pace R, Raraigh K, et al.
Ann Am Thorac Soc
. 2025 Jan;
PMID: 39746161
Rationale: Chronic () airway infection is common and a key contributor to diminished lung function and early mortality in persons with cystic fibrosis (PwCF). Risk factors for chronic among PwCF...
2.
Li D, De Beur S, Hou C, Ruzhnikov M, Seeley H, Cutting G, et al.
JCI Insight
. 2024 Nov;
9(24).
PMID: 39541438
Pseudohypoparathyroidism type 1B (PHP1B) is associated with epigenetic changes in the maternal allele of the imprinted GNAS gene that inhibit expression of the α subunit of Gs (Gsα), thereby leading...
3.
Freeman P, Wagstaff J, Fokkema I, Cutting G, Rehm H, Davies A, et al.
Nat Genet
. 2024 Oct;
56(11):2574.
PMID: 39472695
No abstract available.
4.
Freeman P, Wagstaff J, Fokkema I, Cutting G, Rehm H, Davies A, et al.
Nat Genet
. 2024 Oct;
56(11):2284-2286.
PMID: 39358598
No abstract available.
5.
Ling H, Raraigh K, Pugh E, Aksit M, Zhang P, Pace R, et al.
Am J Hum Genet
. 2024 Sep;
111(10):2203-2218.
PMID: 39260370
To identify modifier loci underlying variation in body mass index (BMI) in persons with cystic fibrosis (pwCF), we performed a genome-wide association study (GWAS). Utilizing longitudinal height and weight data,...
6.
Kavanagh E, Tzeng S, Sharma N, Cutting G, Green J
Biomaterials
. 2024 Sep;
313:122753.
PMID: 39217793
Non-viral nanoparticles (NPs) have seen heightened interest as a delivery method for a variety of clinically relevant nucleic acid cargoes in recent years. While much of the focus has been...
7.
Pion A, Kavanagh E, Joynt A, Raraigh K, Vanscoy L, Langfelder-Schwind E, et al.
Am J Respir Cell Mol Biol
. 2024 Jul;
71(5):577-588.
PMID: 39012815
We broaden the clinical versatility of human nasal epithelial (HNE) cells. HNEs were isolated from 10 participants harboring () variants: 9 with rare variants (Q359R [=2], G480S, R334W [=5], and...
8.
Eastman A, Rosson G, Kim N, Kang S, Raraigh K, Goff L, et al.
J Cyst Fibros
. 2024 Jul;
23(6):1173-1179.
PMID: 38969603
Background: Sweat chloride concentration is used both for CF diagnosis and for tracking CFTR modulator efficacy over time, but the relationship between sweat chloride and lung health is heterogeneous and...
9.
Sheridan M, Aksit M, Pagel K, Hetrick K, Shultz-Lutwyche H, Myers B, et al.
J Cyst Fibros
. 2024 May;
23(4):707-715.
PMID: 38734509
Background: Cystic fibrosis (CF) is caused by deleterious variants in each CFTR gene. We investigated the utility of whole-gene CFTR sequencing when fewer than two pathogenic or likely pathogenic (P/LP)...
10.
Sun Q, Yang Y, Rosen J, Chen J, Li X, Guan W, et al.
Am J Hum Genet
. 2024 Apr;
111(5):990-995.
PMID: 38636510
Since genotype imputation was introduced, researchers have been relying on the estimated imputation quality from imputation software to perform post-imputation quality control (QC). However, this quality estimate (denoted as Rsq)...